ES8608541A1 - Un metodo para extraer interferon inmune humano recombinante intacto - Google Patents

Un metodo para extraer interferon inmune humano recombinante intacto

Info

Publication number
ES8608541A1
ES8608541A1 ES536029A ES536029A ES8608541A1 ES 8608541 A1 ES8608541 A1 ES 8608541A1 ES 536029 A ES536029 A ES 536029A ES 536029 A ES536029 A ES 536029A ES 8608541 A1 ES8608541 A1 ES 8608541A1
Authority
ES
Spain
Prior art keywords
immune interferon
preparation
recombinant human
human immune
interferon
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES536029A
Other languages
English (en)
Other versions
ES536029A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24128466&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES8608541(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of ES536029A0 publication Critical patent/ES536029A0/es
Publication of ES8608541A1 publication Critical patent/ES8608541A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/57—IFN-gamma
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/113—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure
    • C07K1/1136—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure by reversible modification of the secondary, tertiary or quarternary structure, e.g. using denaturating or stabilising agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/249—Interferons
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/811—Interferon
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/948—Microorganisms using viruses or cell lines
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/808—Materials and products related to genetic engineering or hybrid or fused cell technology, e.g. hybridoma, monoclonal products
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/808—Materials and products related to genetic engineering or hybrid or fused cell technology, e.g. hybridoma, monoclonal products
    • Y10S530/809—Fused cells, e.g. hybridoma

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Toxicology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Laminated Bodies (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Lock And Its Accessories (AREA)

Abstract

MODIFICACIONES EN EL PROCEDIMIENTO PARA EXTRAER INTERFERON INMUNE HUMANO RECOMBINANTE INTACTO. CONSISTENTES EN: EXTRAER LOS MICROORGANISMOS TRANSFORMADOS TRAS TRATARLOS CON UN INHIBIDOR DE PROTEASA, COMO GUANIDINA-HCL EN SOLUCION 4 M; QUE LA PROTEINA MADURA TIENE UN PESO MOLECULAR DE 18.000 DALTONS. SE UTILIZA PARA OBTENER LA FORMA DE SECUENCIA IBTACTA DE INTERFERON INMUNE Y ELIMINAR FRAGMENTOS DE DEGRADACION PROTEOLITICA DE LA PREPARACION DE INTERFERON INMUNE PURIFICADO.
ES536029A 1983-09-20 1984-09-19 Un metodo para extraer interferon inmune humano recombinante intacto Expired ES8608541A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/534,039 US4476049A (en) 1983-09-20 1983-09-20 Method for the extraction of immune interferon

Publications (2)

Publication Number Publication Date
ES536029A0 ES536029A0 (es) 1986-07-16
ES8608541A1 true ES8608541A1 (es) 1986-07-16

Family

ID=24128466

Family Applications (1)

Application Number Title Priority Date Filing Date
ES536029A Expired ES8608541A1 (es) 1983-09-20 1984-09-19 Un metodo para extraer interferon inmune humano recombinante intacto

Country Status (20)

Country Link
US (1) US4476049A (es)
EP (1) EP0140127B1 (es)
JP (1) JPS6163295A (es)
KR (1) KR910006602B1 (es)
AT (1) ATE60622T1 (es)
AU (1) AU575588B2 (es)
CA (1) CA1214411A (es)
DE (1) DE3484043D1 (es)
DK (1) DK447584A (es)
ES (1) ES8608541A1 (es)
FI (1) FI80906C (es)
GR (1) GR80404B (es)
HU (1) HU196462B (es)
IL (1) IL72988A (es)
MC (1) MC1626A1 (es)
NO (1) NO159609C (es)
NZ (1) NZ209589A (es)
PH (1) PH20996A (es)
PT (1) PT79231B (es)
ZA (1) ZA846723B (es)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5582824A (en) * 1981-10-19 1996-12-10 Genentech, Inc. Recombinant DES-CYS-TYR-CYS human immune interferon
US4925919A (en) * 1984-04-25 1990-05-15 Roland Mertelsmann Purified interleukin 2
US4853332A (en) * 1982-10-19 1989-08-01 Cetus Corporation Structural genes, plasmids and transformed cells for producing cysteine depleted muteins of biologically active proteins
US4604284A (en) * 1983-09-20 1986-08-05 Hoffmann-La Roche Inc. Homogeneous immune interferon fragment
US4681930A (en) * 1983-09-20 1987-07-21 Hoffmann-La Roche Inc. Immune interferon and a method for its extraction and purification
JPS6079000A (ja) * 1983-10-04 1985-05-04 Takeda Chem Ind Ltd ヒトγ型インタ−フエロン単量体の製造法
US4855238A (en) * 1983-12-16 1989-08-08 Genentech, Inc. Recombinant gamma interferons having enhanced stability and methods therefor
MX9203641A (es) * 1983-12-16 1992-07-01 Genentech Inc Interferones gamma recombinantes que poseen estabilidad mejorada y metodos biotecnologicos para su obtencion.
US4569790A (en) * 1984-03-28 1986-02-11 Cetus Corporation Process for recovering microbially produced interleukin-2 and purified recombinant interleukin-2 compositions
US4908433A (en) * 1984-04-25 1990-03-13 Sloan-Kettering Institute For Cancer Research Uses of interleukin-2
US4908434A (en) * 1984-04-25 1990-03-13 Sloan-Kettering Institute For Cancer Research Process for preparing purified interleukin-2
KR930007429B1 (ko) * 1984-12-27 1993-08-10 산도리 가부시기가이샤 인터페론의 정제방법
DE3511011A1 (de) * 1985-03-27 1986-10-02 Hoechst Ag, 6230 Frankfurt Verfahren zur isolierung und reinigung von (alpha)-interferonen
US4873312A (en) * 1985-04-25 1989-10-10 Amgen Method for purifying interferon and composition of matter produced thereby
WO1986007093A1 (en) * 1985-05-29 1986-12-04 The Green Cross Corporation Process for preparing heterogenic protein
US4929700A (en) * 1987-04-16 1990-05-29 Cetus Corporation Production of purified, biologically active, bacterially produced recombinant human CSF-1
CA1339757C (en) 1987-04-16 1998-03-17 Robert F. Halenbeck Production of purified biologically active, bacterially produced recombinant human csf-1
US4931543A (en) * 1987-05-11 1990-06-05 Cetus Corporation Process for recovering microbially produced interleukin-2
US5162507A (en) * 1987-05-11 1992-11-10 Cetus Corporation Process for recovering purified, oxidized, renatured recombinant interleukin-2 from microorganisms
AU609824B2 (en) * 1987-06-15 1991-05-09 Southern Cross Biotech Pty Ltd. Production of proteins in active forms
IT1219454B (it) * 1988-02-17 1990-05-18 Serono Cesare Ist Ricerca Metodo di rottura alla metionina di polipeptidi contenenti pontidisolfuro
WO1990002175A1 (en) * 1988-08-16 1990-03-08 Novo Nordisk A/S A method of producing polypeptides by culturing eukaryotic cells in the presence of protease inhibitors
DE4440001A1 (de) * 1994-11-09 1996-05-15 Pacesetter Ab Kontaktierung von Glaskohlenstoff-Elektroden
DE19755960C1 (de) * 1997-12-16 1998-11-26 Hoechst Ag Verfahren zum Aufschluß von biologischem Material
DE102011051722A1 (de) 2011-07-11 2013-01-17 Phoenix Conveyor Belt Systems Gmbh Fördergurt mit einer Hybrid-Leiterschleife

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7404589A (nl) * 1974-04-03 1975-10-07 Stichting Rega V Z W Werkwijze voor het stabiliseren van interferon.
NL7404590A (nl) * 1974-04-03 1975-10-07 Stichting Rega V Z W Werkwijze voor het reactiveren van interferon.
US4357422A (en) * 1980-08-14 1982-11-02 Massachusetts Institute Of Technology Method of enhancing interferon production
US4414150A (en) * 1980-11-10 1983-11-08 Genentech, Inc. Hybrid human leukocyte interferons
US4382027A (en) * 1981-08-18 1983-05-03 Meloy Laboratories, Inc. Purification of human immune interferon
AU561343B2 (en) * 1981-10-19 1987-05-07 Genentech Inc. Human immune interferon by recombinant dna
US4388234A (en) * 1981-12-28 1983-06-14 Hoffmann-La Roche Inc. Peptide isolation
EP0088540A3 (en) * 1982-02-22 1984-10-17 Biogen, Inc. Dna sequences, recombinant dna molecules and processes for producing human immune interferon-like polypeptides
AU571460B2 (en) * 1982-09-27 1988-04-21 Cancer Institute Of Japanese Foundation For Cancer Research Alpha interferon dna, recombinant plasmid, engineered organism and alpha interferon polypeptide
GR79124B (es) * 1982-12-22 1984-10-02 Genentech Inc

Also Published As

Publication number Publication date
KR910006602B1 (ko) 1991-08-29
HUT35287A (en) 1985-06-28
GR80404B (en) 1985-01-21
FI80906B (fi) 1990-04-30
DE3484043D1 (de) 1991-03-07
CA1214411A (en) 1986-11-25
MC1626A1 (fr) 1985-09-26
PT79231A (en) 1984-10-01
NO843749L (no) 1985-03-21
NZ209589A (en) 1988-10-28
NO159609C (no) 1989-01-18
IL72988A (en) 1990-02-09
FI80906C (fi) 1990-08-10
AU575588B2 (en) 1988-08-04
EP0140127A1 (en) 1985-05-08
ES536029A0 (es) 1986-07-16
AU3330284A (en) 1985-03-28
DK447584D0 (da) 1984-09-19
JPS6163295A (ja) 1986-04-01
KR850002284A (ko) 1985-05-10
FI843670L (fi) 1985-03-21
IL72988A0 (en) 1984-12-31
DK447584A (da) 1985-03-21
PH20996A (en) 1987-06-22
US4476049A (en) 1984-10-09
NO159609B (no) 1988-10-10
HU196462B (en) 1988-11-28
PT79231B (en) 1986-11-18
FI843670A0 (fi) 1984-09-19
EP0140127B1 (en) 1991-01-30
ZA846723B (en) 1985-04-24
ATE60622T1 (de) 1991-02-15

Similar Documents

Publication Publication Date Title
ES8608541A1 (es) Un metodo para extraer interferon inmune humano recombinante intacto
CS503781A2 (en) Method of mature human leucocytic interferon production
AU577314B2 (en) Human y interferon fragment and production from recombinant microbes
DE3361838D1 (en) Purification method of human interferon
GB8600615D0 (en) Non-polluting method of burning fuel
PH18757A (en) Process of producing glycoprotein
GB2121806B (en) Method of interferon production
HUT40576A (en) Process for producing human leucocite interferon
EP0237956A3 (en) Method of feeding ketoisocaproate to lactating domestic mammals
HUT35289A (en) Immune interferon and process for its purification
GB8714778D0 (en) Antibodies to interferon
DE3174808D1 (en) Method of enhancing interferon production
SU1200578A1 (ru) Способ выделения бактерий - продуцентов лейкоцитарного интерферона человека
IL75262A0 (en) Method for the superinduction of human immune interferon
PL246926A1 (en) Method of producing ceramics-to-metal bonds

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19961217